In vivo analyses, including immune cell subset-specific blockade, multiplex immunohistochemistry of tumor tissues, and scRNA-seq of tumor-infiltrating immune cells, were in line with our in vitro observations, demonstrating that FL/GM-DCs were highly proficient in activating and expanding CD8+ T cells. Here, CD8A is linked to neoplasm.